KATIE LINDSEY: Open Payments
NPI 1215778030 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 34 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $388 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $341 |
| Alnylam Pharmaceuticals Inc. | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $69 |
| PFIZER INC. | 3 | $57 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $56 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: CAMZYOS, ELIQUIS, LEQVIO, AMVUTTRA, LifeVest, ONPATTRO, VERQUVO, JARDIANCE.
Industry payments across TX — which companies pay providers there.
